EdgarLookup

Caris Life Sciences, Inc. — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Caris Life Sciences, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Revenue — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $216.83M Nov 5, 2025
Q2 2025 Jun 30, 2025 $181.40M Aug 12, 2025
Q3 2025 Sep 30, 2024 $101.62M Nov 5, 2025
Q2 2025 Jun 30, 2024 $100.05M Aug 12, 2025

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $24.33M Nov 5, 2025
Q2 2025 Jun 30, 2025 ($71.79M) Aug 12, 2025
Q3 2025 Sep 30, 2024 ($67.73M) Nov 5, 2025
Q2 2025 Jun 30, 2024 ($66.19M) Aug 12, 2025

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $32.64M Nov 5, 2025
Q2 2025 Jun 30, 2025 ($17.99M) Aug 12, 2025
Q3 2025 Sep 30, 2024 ($60.84M) Nov 5, 2025
Q2 2025 Jun 30, 2024 ($67.01M) Aug 12, 2025